| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0264-410X(97)00278-8 |
| P698 | PubMed publication ID | 9682354 |
| P2093 | author name string | Galler R | |
| Santos CN | |||
| Post PR | |||
| Ferreira II | |||
| P433 | issue | 9-10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | yellow fever | Q154874 |
| yellow fever virus | Q836749 | ||
| P304 | page(s) | 1024-1028 | |
| P577 | publication date | 1998-05-01 | |
| P1433 | published in | Vaccine | Q7907941 |
| P1476 | title | Genetic variability among yellow fever virus 17D substrains | |
| P478 | volume | 16 |
| Q40250581 | Adaptation of yellow fever virus 17D to Vero cells is associated with mutations in structural and non-structural protein genes |
| Q40206879 | Adverse events following yellow fever immunization: Report and analysis of 67 neurological cases in Brazil |
| Q34732681 | Biological and immunological characterization of recombinant Yellow Fever 17D viruses expressing a Trypanosoma cruzi Amastigote Surface Protein-2 CD8+ T cell epitope at two distinct regions of the genome |
| Q40420984 | Construction and evaluation of a chimeric pseudoinfectious virus vaccine to prevent Japanese encephalitis. |
| Q36178513 | Cross-species transfer of viruses: implications for the use of viral vectors in biomedical research, gene therapy and as live-virus vaccines |
| Q35246149 | Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil |
| Q40042060 | Development of a recombinant yellow fever vector expressing a HIV clade C founder envelope gp120. |
| Q40255913 | Docking Studies of Adenosine Analogues with NS5 Methyltransferase of Yellow Fever Virus |
| Q24538687 | Evolutionary dynamics of viral attenuation |
| Q40318846 | Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses |
| Q40538989 | Isolation and characterization of wild type yellow fever virus in cases temporally associated with 17DD vaccination during an outbreak of yellow fever in Brazil |
| Q28082036 | Live attenuated vaccines: Historical successes and current challenges |
| Q40546858 | Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys |
| Q40457200 | Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program. |
| Q35104433 | The live-attenuated yellow fever vaccine 17D induces broad and potent T cell responses against several viral proteins in Indian rhesus macaques--implications for recombinant vaccine design |
| Q40301491 | The phylogeny of yellow fever virus 17D vaccines |
| Q26865102 | The yellow fever 17D virus as a platform for new live attenuated vaccines |
| Q56795565 | WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009 |
| Q34118209 | Yellow fever: a reemerging threat |
Search more.